JacobMcLeanDO
Internal Medicine • New York, NYInfectious Disease
Assistant Professor of Medicine, Infectious Diseases
Dr. McLean is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
180 Fort Washington Ave
Fl 2
New York, NY 10032Phone+1 212-305-8039
Education & Training
Touro College of Osteopathic MedicineClass of 2017
Certifications & Licensure
NY State License 2020 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Development of Machine Learning-Based Mpox Surveillance Models in a Learning Health System.Harry Reyes Nieva, Jason Zucker, Emma Tucker, Jacob McLean, Clare DeLaurentis
Medrxiv. 2024-09-27 - Severe Mpox Among People With Advanced Human Immunodeficiency Virus Receiving Prolonged Tecovirimat in New York City.Elizabeth A Garcia, Mary M K Foote, Tristan D McPherson, Maura K Lash, Amma N Bosompem
Open Forum Infectious Diseases. 2024-06-01 - A Prolonged Case of Severe Mpox as an Opportunistic Infection in Advanced AIDS.Matan S Malka, Melissa Parkinson, Jason Zucker, Jacob R McLean, Marcus R Pereira
Cureus. 2024-05-01
Press Mentions
HIV Patients Fare Well with Mpox TreatmentMay 5th, 2023- Mpox Antiviral Outcomes Are Similar Regardless of HIV StatusMay 5th, 2023
- HIV Status Does Not Affect Outcomes of Tecovirimat Treatment for MpoxMay 2nd, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
